Objective To examine the association between 25-hydroxyvitamin D [25(OH)D] deficiency and anemia in a cohort of otherwise-healthy children and to determine whether race modifies the association between 25(OH)D status and hemoglobin (Hgb).
Portions of this study were presented as a poster at the Pediatric Academic Societies' Meeting, Denver, CO, April 30 -May 3, 2011. 27, 28 Serum creatinine was not measured in NHANES participants <12 years of age. Family poverty income ratio was calculated by NHANES as a ratio of reported family income to poverty threshold according to family size, state of residence, and year as defined by the US Census Bureau and was included as a socioeconomic indicator.
Statistical Analyses
All statistical analyses were performed with Stata statistical software, version 11.0 (StataCorp, College Station, Texas). Survey commands were used to account for the NHANES complex sampling design. The statistical significance level was set at a = 0.05. All statistical analyses were 2-sided. Descriptive statistics are reported as mean and SE, median, and IQR, or proportions as noted. Mean 25(OH)D concentrations according to subgroups were compared by independent sample t tests. Logistic regression was used to examine the association of 25(OH)D deficiency or insufficiency with anemia with adjustment for age, sex, race, obesity, CRP, and serum B12 and folate. Linear regression was used to examine the association of 25(OH)D quartiles (whole population and race-specific) with Hgb. In secondary analyses, we performed logistic regressions as described previously in only those subjects with available markers of iron stores and in those with available creatinine data to calculate estimated GFR.
Results
There were 10 410 children included in the analysis. Demographic and clinical characteristics of the cohort overall and by race are presented in Table I . Mean (SE) weighted age of participants was 11.8 (0.13) years, 51.7% were male, 60.8% white, and 14.8% black. Seventeen percent were obese, with a significantly greater proportion of black children meeting criteria for obesity compared with white children (21.5% vs 15.5%, P < .001). The median (IQR) 25(OH)D level in the overall cohort was 25 (20, 30) .
Median (IQR) 25(OH)D was 27 (23, 33) in white subjects vs 17 (12, 22) in black subjects. The overall prevalence of anemia was 4.2%, but this also differed by race, with 2.1% of white children meeting criteria for anemia vs 14.3% of black children (P < .001). There was no difference in mean CRP by racial group, although a slightly greater proportion of black children demonstrated CRP >0.5 mg/dL (P = .04). Figure 1 demonstrates mean 25(OH)D levels by race/ ethnicity and anemia status in the cohort. There was a trend for mean 25(OH)D levels to be consistently lower in the anemic children compared with the nonanemic children across racial/ethnic groups. The difference in mean 25(OH)D levels by anemia status reached statistical significance in the overall cohort (P < .001) and in the non-Hispanic white subjects (P = .02).
The associations between 25(OH)D level, modeled categorically and linearly, and anemia are summarized in Table II . The OR for anemia for those with 25(OH)D levels <30 ng/mL, compared with $30, was 1.93 (95% CI 1.21-3.08, P = .006) in fully adjusted analyses. For those with 25(OH)D levels <20 ng/mL, compared with $20, the adjusted OR for anemia was 1.47 (95% CI 1.14-1.89, P = .004). The OR for anemia for each 1-ng/mL increase in 25(OH)D was 0.97 (95% CI 0.95-0.99, P = .009).
In a secondary logistic regression analysis that included subjects with available ferritin, iron and transferrin saturation levels (n = 2763), those with 25(OH)D <30 ng/mL compared with $30 continued to have an increased risk for anemia (OR 3.51, 95% CI 1.28-9.62, P = .016). The trend was similar for those with 25(OH)D levels <20 ng/mL, although statistical significance was not reached (OR 1.47, 95% CI 0.87-2.48, P = .14). Among those subjects with estimated GFR available (n = 6154), very few demonstrated values consistent with CKD; only 0.004% had estimated GFR <60 mL/min per 1.73 m 2 , a GFR cut-off most often used to define CKD in adults and below which anemia related to CKD becomes prevalent. 29 (Figure 2 ; available at www.jpeds.com). To examine the extent to which race modifies the observed association between 25(OH)D level and Hgb, we performed a linear regression by 25(OH)D quartile stratified by race (Table III) . Using whole population quartile values in the full cohort, we noted significant increases in Hgb in each of the upper 25(OH)D quartiles compared with the first quartile of 25(OH)D <20 ng/mL. In a race-stratified analysis, the magnitude and significance of the increase in Hgb seen in the upper 25(OH)D quartiles in the white children was consistent with increases observed in the whole population. However, in the black children, no significant change in Hgb was observed in the greater quartiles compared with lowest 25(OH)D quartile.
We then conducted a regression analysis in the black children by using the non-Hispanic-black race-specific 25(OH) D quartiles (Table IV ; available at www.jpeds.com). This demonstrated increases in Hgb in greater 25(OH)D quartiles compared with the lowest quartile, which were of similar magnitude to the increases observed in the quartile analysis for white children: second vs first (<12 ng/mL) quartile, Hgb increased by 0.240 (95% CI 0.096-0.384) g/dL, P = .002; third vs first quartile, Hgb increased by 0.116 (95% CI À0.019 to 0.251) g/dL, P = .091; and fourth vs first quartile, Hgb increased by 0.146 (95% CI 0.025-0.267) g/dL, P = .019.
Discussion
This study demonstrates that in a large, population-based cohort of healthy US children, lower 25(OH)D levels were associated with increased risk for anemia. The observed association between vitamin D status and anemia was independent of other factors that may contribute to anemia risk, including obesity, inflammation, socioeconomic status, and nutritional status, including B12, folate, and iron deficiency. Furthermore, an association between 25(OH)D level and Hgb was observed in children of both black and white race, but the 25(OH)D levels at which this association becomes apparent differed by race and were lower in black children. Among white subjects, 25(OH)D levels in the upper quartiles ($20 ng/mL) were associated with a nearly 0.2 g/dL greater Hgb compared with those <20 ng/mL, and in black children, Hgb was greater among those with 25(OH) D levels >11 ng/mL. Vitamin D has long been recognized for its role in regulating calcium, phosphorus, and bone metabolism, but in recent years it has received attention as a regulator of a variety of biological functions, including immune function, cellular proliferation, and cardiovascular function. 5, 30, 31 An accumulating body of evidence suggests that 25(OH)D deficiency may also play a role in the pathogenesis of anemia. Lower 25(OH)D levels have been associated with anemia/lower Hgb values in population-based samples of US adults 13, 14 and in adults with nondialysis CKD and end-stage kidney disease, 9, 10, [32] [33] [34] end-stage heart failure, 12 and type 2 diabetes. 11 Furthermore, retrospective cohort studies in adults with CKD have demonstrated that vitamin D supplementation may improve the management of anemia and decrease dose requirements for erythropoiesis-stimulating agents (ESAs), suggesting that vitamin D plays a role in 32, 33 Among anemic patients with nondialysis CKD treated with ESAs, ergocalciferol supplementation to normalize 25(OH)D values to $30 ng/mL was associated with a 24% decrease in the ESA dose required to maintain Hgb in the range of 11-12 g/dL. 32 In a study of >100 adults on chronic hemodialysis, ergocalciferol supplementation to normalize 25(OH)D was associated with a decrease in the ESA dose required to maintain Hgb targets in the majority of subjects. 33 There are several possible mechanisms to explain the association of vitamin D deficiency with anemia. Vitamin D deficiency in children has been shown to be associated with lifestyle and nutritional factors such as obesity and decreased milk intake. 1 However, in the present study, the association between 25(OH)D status and anemia remained after we adjusted for obesity and additional markers of nutritional status, including B12 and folate levels and, in a subcohort of children, iron markers, suggesting that there are other explanatory mechanisms. Vitamin D and its metabolites are present in many tissues, as are the receptors for the active form of vitamin D, calcitriol. Although calcitriol production for the regulation of bone mineral metabolism takes place via the action of the 1-a-hydroxylase enzyme in renal tissue, there are multiple extrarenal sites at which locally produced calcitriol regulates host-cell DNA, and from which the extra-skeletal actions of vitamin D are controlled. 5, 35 There are data to suggest that inadequate levels of 25(OH)D leading to decreased local calcitriol production in the bone marrow may limit erythropoiesis; calcitriol has a direct proliferative effect on erythroid burst-forming units that is synergistic with endogenously produced erythropoietin, and it also up-regulates expression of the erythropoietin receptor on erythroid progenitor cells. 33, 36, 37 Calcitriol also plays a key role in the regulation of immune function by inhibiting the expression of proinflammatory cytokines by a variety of immune cells, thus providing negative feedback to prevent excessive inflammation. 5 The immunomodulatory effects of vitamin D may be central to its role in preventing anemia via modulation of systemic cytokine production, which may in turn suppress specific inflammatory pathways which contribute to the development of anemia. In a study of adults ages $60 years in NHANES, Perlstein et al 14 demonstrated an association between vitamin D deficiency and anemia that became statistically significant at a 25(OH)D level of 24 ng/mL. They also found a strong association between vitamin D deficiency and anemia of inflammation compared with both nonanemic subjects and subjects with other anemia subtypes. Interestingly, they also found that among subjects with anemia of inflammation, non-Hispanic blacks were overrepresented, comprising nearly 44% of the group. 14 Although we controlled for CRP in our multivariate models, it may not be the most sensitive marker of inflammation in children who could have a variety of infectious stimuli causing transient decreases in Hgb, including viral infections. It is possible that there are other inflammatory mediators, unmeasured in the pediatric NHANES cohort, which are associated with lower levels of 25(OH)D. The role of inflammation in the etiology of anemia has been further clarified through study of the iron-regulatory protein hepcidin, an inflammation-induced negative regulator of erythropoiesis. 38, 39 Low levels of calcitriol have been found to be associated with increased hepcidin levels in adults with CKD. 40 Our finding that the 25(OH)D threshold above which Hgb increases differs by race suggests a possible differential sensitivity to the effects of vitamin D by race. This finding is not unique to Hgb, as recently published NHANES studies also have demonstrated racial variation in 25(OH)D threshold for other adverse health effects. In a study of adults in NHANES 2003-2006, bone mineral density was significantly decreased in those with lower levels of 25(OH)D among non-Hispanic whites but not in non-Hispanic blacks, 41 and in another community-based study researchers found that black women have increased serum parathyroid hormone levels at lower 25(OH)D levels compared with white women. 42 In adults in NHANES III, 25(OH)D deficiency (defined as level <15 ng/mL) was associated with an increased risk of fatal stroke in non-Hispanic whites but not in blacks. 43 Total 25(OH)D levels have not been consistently correlated with bone mineral density in the literature, and bioavailable vitamin D, which is the fraction of circulating 25(OH)D that is unbound to either vitamin D binding protein or albumin and is thus available to effect biologic actions, is strongly correlated with bone mineral density. 44 A recent study performed in a small cohort of healthy young adults revealed that mean levels of the vitamin D binding protein were significantly lower in nonwhite subjects compared with white subjects, with a trend towards increased bioavailable vitamin D among the nonwhite subjects. 44 Thus, the variation by race in total 25(OH)D levels at which certain adverse health effects are observed may be explained by racial differences in bioavailability of vitamin D.
Our study has several strengths, including a nationally representative, population-based sample of children and adolescents and standardized data collection and quality control procedures. This was a cross-sectional study, and thus the association between vitamin D deficiency and lower Hgb cannot be assumed to be causal. We did not have access to data on iron deficiency, one of the most common causes of anemia in children, in the majority of subjects, but sensitivity analyses conducted among subjects with iron data showed similar direction and magnitude of associations between 25(OH)D deficiency and anemia. Hereditary hemoglobinopathies may be associated with lower Hgb levels, particularly in black children, but we did not have access to data to estimate the prevalence of these traits. NHANES does not analyze vitamin D binding protein, preventing the determination of bioavailable 25(OH)D. n 
